Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of DW5121 Compared to DW51211 and DW51212 [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update reports a study comparing DW5121 with DW51211 and DW51212 in acute bronchitis; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis

Drugs mentioned

• DW5121
• DW51211
• DW51212

Snippet

Sponsor: Daewon Pharmaceutical Co., Ltd. | Conditions: Acute Bronchitis | Phase 3 | Status: COMPLETED